Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study

Joan L. Walker; Mark F. Brady; Lari Wenzel; Gini F. Fleming; Helen Q. Huang; Paul A. Disilvestro; Keiichi Fujiwara; David S. Alberts; Wenxin Zheng; Krishnansu S. Tewari; David E. Cohn; Matthew A. Powell; Linda Van Le; Susan A. Davidson; Heidi J. Gray; Peter G. Rose; Carol Aghajanian; Tashanna Myers; Angeles Alvarez Secord; Stephen C. Rubin; Robert S. Mannel

doi:10.1097/01.ogx.0000576976.42254.c2

Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study

Joan L. Walker, Mark F. Brady, Lari Wenzel, Gini F. Fleming, Helen Q. Huang, Paul A. Disilvestro, Keiichi Fujiwara, David S. Alberts, Wenxin Zheng, Krishnansu S. Tewari, David E. Cohn, Matthew A. Powell, Linda Van Le, Susan A. Davidson, Heidi J. Gray, Peter G. Rose, Carol Aghajanian, Tashanna Myers, Angeles Alvarez Secord, Stephen C. RubinRobert S. Mannel

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	474-476
Number of pages	3
Journal	Obstetrical and Gynecological Survey
Volume	74
Issue number	8
DOIs	https://doi.org/10.1097/01.ogx.0000576976.42254.c2
State	Published - Aug 1 2019
Externally published	Yes

ASJC Scopus subject areas

Obstetrics and Gynecology

Access to Document

10.1097/01.ogx.0000576976.42254.c2

Cite this

Walker, J. L., Brady, M. F., Wenzel, L., Fleming, G. F., Huang, H. Q., Disilvestro, P. A., Fujiwara, K., Alberts, D. S., Zheng, W., Tewari, K. S., Cohn, D. E., Powell, M. A., Van Le, L., Davidson, S. A., Gray, H. J., Rose, P. G., Aghajanian, C., Myers, T., Secord, A. A., ... Mannel, R. S. (2019). Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study. Obstetrical and Gynecological Survey, 74(8), 474-476. https://doi.org/10.1097/01.ogx.0000576976.42254.c2

Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study. / Walker, Joan L.; Brady, Mark F.; Wenzel, Lari et al.
In: Obstetrical and Gynecological Survey, Vol. 74, No. 8, 01.08.2019, p. 474-476.

Research output: Contribution to journal › Comment/debate › peer-review

Walker, JL, Brady, MF, Wenzel, L, Fleming, GF, Huang, HQ, Disilvestro, PA, Fujiwara, K, Alberts, DS, Zheng, W, Tewari, KS, Cohn, DE, Powell, MA, Van Le, L, Davidson, SA, Gray, HJ, Rose, PG, Aghajanian, C, Myers, T, Secord, AA, Rubin, SC & Mannel, RS 2019, 'Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study', Obstetrical and Gynecological Survey, vol. 74, no. 8, pp. 474-476. https://doi.org/10.1097/01.ogx.0000576976.42254.c2

@article{307405e4e4154e559b83006d35b127e0,

title = "Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study",

author = "Walker, {Joan L.} and Brady, {Mark F.} and Lari Wenzel and Fleming, {Gini F.} and Huang, {Helen Q.} and Disilvestro, {Paul A.} and Keiichi Fujiwara and Alberts, {David S.} and Wenxin Zheng and Tewari, {Krishnansu S.} and Cohn, {David E.} and Powell, {Matthew A.} and {Van Le}, Linda and Davidson, {Susan A.} and Gray, {Heidi J.} and Rose, {Peter G.} and Carol Aghajanian and Tashanna Myers and Secord, {Angeles Alvarez} and Rubin, {Stephen C.} and Mannel, {Robert S.}",

year = "2019",

month = aug,

day = "1",

doi = "10.1097/01.ogx.0000576976.42254.c2",

language = "English (US)",

volume = "74",

pages = "474--476",

journal = "Obstetrical and Gynecological Survey",

issn = "0029-7828",

publisher = "Lippincott Williams and Wilkins",

number = "8",

}

TY - JOUR

T1 - Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma

T2 - An NRG oncology/gynecologic oncology group study

AU - Walker, Joan L.

AU - Brady, Mark F.

AU - Wenzel, Lari

AU - Fleming, Gini F.

AU - Huang, Helen Q.

AU - Disilvestro, Paul A.

AU - Fujiwara, Keiichi

AU - Alberts, David S.

AU - Zheng, Wenxin

AU - Tewari, Krishnansu S.

AU - Cohn, David E.

AU - Powell, Matthew A.

AU - Van Le, Linda

AU - Davidson, Susan A.

AU - Gray, Heidi J.

AU - Rose, Peter G.

AU - Aghajanian, Carol

AU - Myers, Tashanna

AU - Secord, Angeles Alvarez

AU - Rubin, Stephen C.

AU - Mannel, Robert S.

PY - 2019/8/1

Y1 - 2019/8/1

UR - http://www.scopus.com/inward/record.url?scp=85070760342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070760342&partnerID=8YFLogxK

U2 - 10.1097/01.ogx.0000576976.42254.c2

DO - 10.1097/01.ogx.0000576976.42254.c2

M3 - Comment/debate

AN - SCOPUS:85070760342

SN - 0029-7828

VL - 74

SP - 474

EP - 476

JO - Obstetrical and Gynecological Survey

JF - Obstetrical and Gynecological Survey

IS - 8

ER -

Randomized clinical trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/gynecologic oncology group study

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this